The impact of EPA and DHA on blood lipids and lipoprotein metabolism: Influence of apoE genotype

Proceedings of the Nutrition Society

Volumn 66, Issue 1, 2007, Pages 60-68

  Anil, Eliz ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

ApoE genotype; Fish oils; Long chain n 3 PUFA; TAG

Indexed keywords

APOLIPOPROTEIN E; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ARACHIDIC ACID; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONFERENCE PAPER; GENE LOCUS; GENOTYPE; HEART PROTECTION; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MORBIDITY; MORTALITY; STRUCTURE ANALYSIS; SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; DRUG EFFECT; GENETICS; LIPID METABOLISM; METABOLISM; REVIEW;

APOLIPOPROTEINS E; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSANOIC ACIDS; FISH OILS; GENOTYPE; HUMANS; LIPID METABOLISM; LIPIDS; TRIGLYCERIDES;

EID: 34248166597     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665107005307     Document Type: Conference Paper

References (67)

1. Abbey M, Clifton P, Kestin M, Belling B & Nestel P (1990) Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 10, 85-94.
2. Agren JJ, Hanninen O, Julkunen A, Fogelholm L, Vidgren H, Schwab U, Pynnonen O & Uusitupa M (1996) Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. European Journal of Clinical Nutrition 50, 765-771.
3. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC & Ma J (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. New England Journal of Medicine 346, 1113-1118.
4. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL & Willett WC (1995) Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. New England Journal of Medicine 332, 977-982.
5. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P & Lau J (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19-30.
6. Bang H, Dyerberg J & Sinclair H (1980) The composition of the Eskimo food in north western Greenland. American Journal of Clinical Nutrition 33, 2657-2661.
7. Bocksch L, Stephens T, Lucas A & Singh B (2001) Apolipoprotein E: possible therapeutic target for atherosclerosis. Current Drug Targets Cardiovascular and Haematological Disorders 1, 93-106.
8. Bonaa KH, Bjerve KS & Nordoy A (1992) Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans. Arteriosclerosis and Thrombosis 12, 675-681.
9. Brown AJ & Roberts DC (1991) Moderate fish oil intake improves lipemic response to a standard fat meal. A study in 25 healthy men. Arteriosclerosis and Thrombosis 11, 457-466.
10. Bucher HC, Hengstler P, Schindler C & Meier G (2002) N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. American Journal of Medicine 112, 298-304.
11. Buckley R, Shewring B, Turner R, Yaqoob P & Minihane AM (2004) Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. British Journal of Nutrition 92, 477-483.
12. Burr M, Fehily A, Gilbert J, Rogers S, Holliday R, Sweetnam P, Elwood P & Deadman N (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet ii, 757-761.
13. Burr ML (2007) Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel. Proceedings of the Nutrition Society 66, 9-15.
14. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA & Elwood PC (2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. European Journal of Clinical Nutrition 57, 193-200.
15. Buttriss J (1999) n-3 Fatty Acids and Health, pp. 4-37. London: BNF.
16. Calder PC (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clinical Science (London) 107, 1-11.
17. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW & Schaefer EJ (1992) Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis and Thrombosis 12, 187-195.
18. Childs MT, King IB & Knopp RH (1990) Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenoic acid and docosahexaenoic acid. American Journal of Clinical Nutrition 52, 632-639.
19. Davignon J, Gregg RE & Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21.
20. Dreon DM, Fernstrom HA, Miller B & Krauss RM (1995) Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arteriosclerosis, Thrombosis, and Vascular Biology 15, 105-111.
21. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE & Stroehla BC (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. American Journal of Epidemiology 155, 487-495.
22. Garner B (2006) Structure function relationship of apolipoprotein-E oligosaccharides. http://www.bmsf.unsw.edu.au/research/projects/apoE.html
23. Griffin B (1995) Low-density lipoprotein heterogeneity. Baillieres Clinical Endocrinology and Metabolism 9, 687-703.
24. Grimsgaard S, Bonaa KH, Hansen JB & Nordoy A (1997) Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. American Journal of Clinical Nutrition 66, 649-659.
25. Hagberg JM, Wilund KR & Ferrell RE (2000) APO E gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiological Genomics 4, 101-108.
26. Hamazaki T, Urakaze M, Sawazaki S, Yamazaki K, Taki H & Yano S (1988) Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. Atherosclerosis 73, 157-160.
27. Harris W (1997) n-3 Fatty acids and serum lipoproteins: Human studies. American Journal of Clinical Nutrition 65, 1645S-1654S.
28. Harris W, Connor W, Alam N & Illingworth D (1988) Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids. Journal of Lipid Research 29, 1451-1460.
29. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR & Greenland P (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109, 2705-2711.
30. Henderson L, Gregory J and Swann G (2002) The National Diet and Nutrition Survey: Adults Aged 19 to 64 Years. vol. 1: Types and Quantities of Foods Consumed. London: The Stationery Office.
31. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ et al. (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. British Medical Journal 332, 752-760.
32. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D & Manson JE (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. Journal of the American Medical Association 287, 1815-1821.
33. Hu FB, Cho E, Rexrode KM, Albert CM & Manson JE (2003) Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 107, 1852-1857.
34. Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE & Willett WC (2000) Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. New England Journal of Medicine 343, 530-537.
35. Jackson KG, Robertson MD, Fielding BA, Frayn KN & Williams CM (2002) Olive oil increases the number of triacylglycerol-rich chylomicron particles compared with other oils: an effect retained when a second standard meal is fed. American Journal of Clinical Nutrition 76, 942-949.
36. Kris-Etherton PM, Harris WS & Appel LJ (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23, e20-e30.
37. Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, Stewart PW, Ershow A et al. (1997) ApoE genotype does not predict lipid response to changes in dietary saturated fatty acids in a heterogeneous normolipidemic population. Arteriosclerosis, Thrombosis, and Vascular Biology 17, 2914-2923.
38. Leigh-Firbank EC, Minihane AM, Leake DS, Wright JW, Murphy MC, Griffin BA & Williams CM (2002) Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. British Journal of Nutrition 87, 435-445.
39. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT & Schaefer EJ (1994) Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. Journal of Lipid Research 35, 1965-1975.
40. Lovegrove JA, Brooks CN, Murphy MC, Gould BJ & Williams CM (1997) Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake. British Journal of Nutrition 78, 223-236.
41. Mahley RW & Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annual Review of Genomics and Human Genetics 1, 507-537.
42. Marchioli R (2001) Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-prevenzione trial. European Heart Journal 3, Suppl. D, D85-D97.
43. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, Quinet E, Tall AR, Marcel YL & McPherson R (1993) Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. Journal of Lipid Research 34, 437-446.
44. Minihane AM, Khan S, Leigh-Firbank EC, Talmud P, Wright JW, Murphy MC, Griffin BA & Williams CM (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arteriosclerosis, Thrombosis, and Vascular Biology 20, 1990-1997.
45. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD & Beilin LJ (2000a) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins LDL particle size, glucose, and insulin in mildly hyperlipidemic men. American Journal of Clinical Nutrition 71, 1085-1094.
46. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB & Beilin LJ (2000b) Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102, 1264-1269.
47. Nenseter MS, Rustan AC, Lund-Katz S, Soyland E, Maelandsmo G, Phillips MC & Drevon CA (1992) Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans. Arteriosclerosis and Thrombosis 12, 369-379.
48. Ness AR, Hughes J, Elwood PC, Whitley E, Smith GD & Burr ML (2002) The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART). European Journal of Clinical Nutrition 56, 512-518.
49. Nestel P, Shige H, Pomeroy S, Cehun M, Abbey M & Raederstorff D (2002) The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. American Journal of Clinical Nutrition 76, 326-330.
50. Newman WP, Middaugh JP, Propst MT & Rogers DR (1993) Atherosclerosis in Alaska natives and non-natives. Lancet 341, 1056-1057.
51. Osler M, Andreasen AH & Hoidrup S (2003) No inverse association between fish consumption and risk of death from all-causes, and incidence of coronary heart disease in middle-aged Danish adults. Journal of Clinical Epidemiology 56, 274-279.
52. Rambjor GS, Walen AI, Windsor SL & Harris WS (1996) Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31, Suppl., S45-S49.
53. Robertson MD, Jackson KG, Fielding BA, Morgan LM, Williams CM & Frayn KN (2002) Acute ingestion of a meal rich in n-3 polyunsaturated fatty acids results in rapid gastric emptying in humans. American Journal of Clinical Nutrition 76, 232-238.
54. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH, Li Z, Rasmussen H, McNamara JR & Ordovas JM (1995) Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arteriosclerosis, Thrombosis, and Vascular Biology 15, 1079-1085.
55. Scientific Advisory Committee on Nutrition (2004) Advice on Fish Consumption: Benefits & Risks. London: the Stationery Office; available at http://www.sacn.gov.uk/pdfs/fics_sacn_advice_fish.pdf
56. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM & Visvikis S (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clinical Chemistry 41, 1068-1086.
57. Song Y, Stampfer MJ & Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Annals of Internal Medicine 141, 137-147.
58. Sorensen NS, Marckmann P, Hoy CE, van Duyvenvoorde W & Princen HM (1998) Effect of fish-oil-enriched margarine on plasma lipids, low-density-lipoprotein particle composition, size, and susceptibility to oxidation. American Journal of Clinical Nutrition 68, 235-241.
59. Stark KD & Holub BJ (2004) Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. American Journal of Clinical Nutrition 79, 765-773.
60. Stark KD, Park EJ, Maines VA & Holub BJ (2000) Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial. American Journal of Clinical Nutrition 72, 389-394.
61. Suzukawa M, Abbey M, Howe PR & Nestel PJ (1995) Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. Journal of Lipid Research 36, 473-484.
62. Theobald HE, Chowienczyk PJ, Whittall R, Humphries SE & Sanders TA (2004) LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. American Journal of Clinical Nutrition 79, 558-563.
63. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC & Grimble RF (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361, 477-485.
64. Tinker LF, Parks EJ, Behr SR, Schneeman BO & Davis PA (1999) (n-3) Fatty acid supplementation in moderately hypertriglyceridaemic adults changes postprandial lipid and apolipoprotein B responses to a standardized test meal. Journal of Nutrition 129, 1126-1134.
65. Williams C, Moore F, Morgan L & Wright J (1992) Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. British Journal of Nutrition 68, 655-666.
66. Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF & Beilin LJ (2002) Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. American Journal of Clinical Nutrition 76, 1007-1015.
67. Zampelas A, Murphy M, Morgan LM & Williams CM (1994) Postprandial lipoprotein lipase, insulin and gastric inhibitory polypeptide responses to test meals of different fatty acid composition: comparison of saturated, n-6 and n-3 polyunsaturated fatty acids. European Journal of Clinical Nutrition 48, 849-858.